1. Research and Publication:The light and the dark sideSimon [email protected] North Shore Hospital 2. @icuresearch 3. Disclosureshttp://www.nejm.org/doi/suppl/10.1056/NEJMra1208705/suppl_file/nejmra1208705_disclosures.pdfor…
Slide 1Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Visual Function After Ranibizumab Mitchell P, Bressler N, Tolley K, et al; RESTORE Study Group.…
Slide 1 HPS2-THRIVE: Randomized placebo-controlled trial of ER niacin and laropiprant in 25,673 patients with pre-existing cardiovascular disease. Jane Armitage on behalf…
HPS2-THRIVE: Randomized placebo-controlled trial of ER niacin and laropiprant in 25,673 patients with pre-existing cardiovascular disease. Jane Armitage on behalf of the…
HPS2-THRIVE: Randomized placebo-controlled trial of ER niacin and laropiprant in 25,673 patients with pre-existing cardiovascular disease. Jane Armitage on behalf of the…
HPS2-THRIVE: Randomized placebo-controlled trial of ER niacin and laropiprant in 25,673 patients with pre-existing cardiovascular disease. Jane Armitage on behalf of the…
Progesterone and Traumatic Brain Injury from: http://www.drugs.com/progesterone.html Progesterone is a female hormone important for the regulation of ovulation and menstruation.…
Outcome Adjudication HPS2-THRIVE: Randomized placebo-controlled trial of ER niacin and laropiprant in 25,673 patients with pre-existing cardiovascular disease. Jane Armitage…